Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)-Reference-Cited by-同舟云学术

Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)

Published:2011-07-16 Issue:3 Volume:130 Page:993-1002
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Sucheston Lara E.,Zhao Hua,Yao Song,Zirpoli Gary,Liu Song,Barlow William E.,Moore Halle C. F.,Thomas Budd G.,Hershman Dawn L.,Davis Warren,Ciupak Gregory L.,Stewart James A.,Isaacs Claudine,Hobday Timothy J.,Salim Muhammad,Hortobagyi Gabriel N.,Gralow Julie R.,Livingston Robert B.,Albain Kathy S.,Hayes Daniel F.,Ambrosone Christine B.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-011-1671-3.pdf

Reference25 articles.

1. Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ et al (2003) Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol 21:976–983

2. Mamounas EP, Bryant J, Lembersky B, Fehrenbacher L, Sedlacek SM et al (2005) Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28. J Clin Oncol 23:3686–3696

3. Martin M, Pienkowski T, Mackey J, Pawlicki M, Guastalla JP et al (2005) Adjuvant docetaxel for node-positive breast cancer. N Engl J Med 352:2302–2313

4. Roché H, Fumoleau P, Spielmann M, Canon JL, Delozier T et al (2006) Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial. J Clin Oncol 24:5664–5671

5. Perez EA (2005) TAC—a new standard in adjuvant therapy for breast cancer? N Engl J Med 352:2346–2348

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using maximum plasma concentration (Cmax) to personalize taxane treatment and reduce toxicity;Cancer Chemotherapy and Pharmacology;2024-05-11

2. Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study;Swiss Medical Weekly;2023-03-30

3. Pan-cancer chemoresistance-associated genes, affected pathways and potential therapeutic targets;Human Gene;2023-02

4. Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study;Breast Cancer Research;2022-10-28

5. Neuropathic pain prevalence and risk factors in head and neck cancer survivors;Head & Neck;2022-09-21